References
- Melo JV, Barnes DJ. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 2007;7:441–453.
- Corbin AS, Agarwal A, Loriaux M, . Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J Clin Invest 2011;121:396–409.
- Perrotti D, Jamieson C, Goldman J, . Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest 2010;120:2254–2264.
- Slupphaug G, Kavli B, Krokan HE. The interacting pathways for prevention and repair of oxidative DNA damage. Mutat Res 2003;531:231–251.
- Nieborowska-Skorska M, Kopinski PK, Ray R, . Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors. Blood 2012;119:4253–4263.
- Zhang B, Strauss AC, Chu S, . Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate. Cancer Cell 2010; 17:427–442.
- Subramanian A, Tamayo P, Mootha VK, . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005;102:15545–15550.
- Diehn M, Cho RW, Lobo NA, . Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009;458:780–783.
- Ye XQ, Li Q, Wang GH, . Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells. Int J Cancer 2011;129:820–831.
- Abdel-Wahab O, Levine RL. Metabolism and the leukemic stem cell. J Exp Med 2010;207:677–680.
- Koptyra M, Cramer K, Slupianek A, . BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress. Leukemia 2008;22:1969–1972.
- Koptyra M, Falinski R, Nowicki MO, . BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance. Blood 2006;108:319–327.
- Skorski T. Chronic myeloid leukemia cells refractory/resistant to tyrosine kinase inhibitors are genetically unstable and may cause relapse and malignant progression to the terminal disease state. Leuk Lymphoma 2011;52(Suppl. 1):23–29.
- Petzer AL, Eaves CJ, Barnett MJ, . Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia. Blood 1997;90:64–69.
- Pihlajamaki J, Boes T, Kim EY, . Thyroid hormone-related regulation of gene expression in human fatty liver. J Clin Endocrinol Metab 2009;94:3521–3529.
- Xu F, Ackerley C, Maj MC, . Disruption of a mitochondrial RNA-binding protein gene results in decreased cytochrome b expression and a marked reduction in ubiquinol-cytochrome c reductase activity in mouse heart mitochondria. Biochem J 2008;416:15–26.
- Jung HJ, Shim JS, Lee J, . Terpestacin inhibits tumor angiogenesis by targeting UQCRB of mitochondrial complex III and suppressing hypoxia-induced reactive oxygen species production and cellular oxygen sensing. J Biol Chem 2010;285:11584–11595.
- Hitosugi T, Fan J, Chung TW, . Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Mol Cell 2011;44:864–877.